Epidermal growth factor upregulates serotonin transporter in human intestinal epithelial cells via transcriptional mechanisms.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Gill RK;Gill RK; Anbazhagan AN; Esmaili A; Kumar A; Nazir S; Malakooti J; Alrefai WA; Saksena S
  • Source:
    American journal of physiology. Gastrointestinal and liver physiology [Am J Physiol Gastrointest Liver Physiol] 2011 Apr; Vol. 300 (4), pp. G627-36. Date of Electronic Publication: 2011 Jan 27.
  • Publication Type:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901227 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-1547 (Electronic) Linking ISSN: 01931857 NLM ISO Abbreviation: Am J Physiol Gastrointest Liver Physiol Subsets: MEDLINE
    • Publication Information:
      Original Publication: Bethesda, MD : American Physiological Society
    • Subject Terms:
      Epidermal Growth Factor/*genetics ; Epithelial Cells/*metabolism ; Serotonin Plasma Membrane Transport Proteins/*genetics ; Transcriptional Activation/*genetics; Analysis of Variance ; Caco-2 Cells ; Electrophoretic Mobility Shift Assay ; Epidermal Growth Factor/metabolism ; Epidermal Growth Factor/pharmacology ; Epithelial Cells/drug effects ; ErbB Receptors/genetics ; ErbB Receptors/metabolism ; Gene Expression Regulation/drug effects ; Gene Expression Regulation/genetics ; Humans ; Promoter Regions, Genetic ; Proto-Oncogene Proteins c-jun/genetics ; Proto-Oncogene Proteins c-jun/metabolism ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; Serotonin Plasma Membrane Transport Proteins/metabolism ; Transcription, Genetic/drug effects ; Transcription, Genetic/genetics ; Transcriptional Activation/drug effects ; Transfection ; Up-Regulation/drug effects ; Up-Regulation/genetics
    • Abstract:
      Serotonin transporter (SERT) regulates extracellular availability of serotonin and is a potential pharmacological target for gastrointestinal disorders. A decrease in SERT has been implicated in intestinal inflammatory and diarrheal disorders. However, little is known regarding regulation of SERT in the intestine. Epidermal growth factor (EGF) is known to influence intestinal electrolyte and nutrient transport processes and has protective effects on intestinal mucosa. Whether EGF regulates SERT in the human intestine is not known. The present studies examined the regulation of SERT by EGF, utilizing Caco-2 cells grown on Transwell inserts as an in vitro model. Treatment with EGF from the basolateral side (10 ng/ml, 24 h) significantly stimulated SERT activity (∼2-fold, P < 0.01) and mRNA levels compared with control. EGF increased the activities of the two alternate promoter constructs for human SERT gene: SERT promoter 1 (hSERTp1, upstream of exon 1a) and SERT promoter 2 (hSERTp2, upstream of exon 2). Inhibition of EGF receptor (EGFR) tyrosine kinase activity by PD168393 (1 nM) blocked the stimulatory effects of EGF on SERT promoters. Progressive deletions of the SERT promoter indicated that the putative EGF-responsive elements are present in the -672/-472 region of the hSERTp1 and regions spanning -1195/-738 and -152/+123 of hSERTp2. EGF markedly increased the binding of Caco-2 nuclear proteins to the potential AP-1 cis-elements present in EGF-responsive regions of hSERTp1 and p2. Overexpression of c-jun but not c-fos specifically transactivated hSERTp2, with no effects on hSERTp1. Our findings define novel mechanisms of transcriptional regulation of SERT by EGF via EGFR at the promoter level that may contribute to the beneficial effects of EGF in gut disorders.
    • References:
      J Nutr. 2008 Jul;138(7):1355-9. (PMID: 18567760)
      Neurogastroenterol Motil. 2010 Jul;22(7):826-34, e229. (PMID: 20219086)
      J Biol Chem. 2005 Mar 25;280(12):11859-68. (PMID: 15637072)
      Gastroenterology. 1986 Nov;91(5):1134-40. (PMID: 3489652)
      Am J Physiol Cell Physiol. 2001 Aug;281(2):C504-13. (PMID: 11443049)
      Am J Physiol Gastrointest Liver Physiol. 2002 Mar;282(3):G491-500. (PMID: 11841999)
      Gastroenterology. 2004 Jun;126(7):1657-64. (PMID: 15188158)
      Am J Physiol. 1994 Nov;267(5 Pt 1):G892-900. (PMID: 7977752)
      J Biol Chem. 1995 Mar 17;270(11):6314-9. (PMID: 7890769)
      Gastroenterology. 2005 Apr;128(4):962-74. (PMID: 15825078)
      Ann N Y Acad Sci. 2000;915:30-42. (PMID: 11193592)
      J Clin Invest. 2007 Feb;117(2):428-37. (PMID: 17256057)
      Gastroenterology. 1991 Sep;101(3):640-9. (PMID: 1860628)
      Am J Physiol Gastrointest Liver Physiol. 2008 Jan;294(1):G254-62. (PMID: 17991706)
      Anal Biochem. 1976 May 7;72:248-54. (PMID: 942051)
      J Pharmacol Exp Ther. 2003 Jul;306(1):355-62. (PMID: 12682218)
      Mol Cell Biol. 1989 Mar;9(3):1327-31. (PMID: 2498646)
      Proc Natl Acad Sci U S A. 1989 May;86(9):3036-40. (PMID: 2566164)
      Am J Physiol. 1997 Nov;273(5):G1014-22. (PMID: 9374697)
      Proc Soc Exp Biol Med. 1992 Dec;201(3):289-95. (PMID: 1332072)
      Am J Physiol Cell Physiol. 2003 May;284(5):C1262-71. (PMID: 12529244)
      Am J Physiol Cell Physiol. 2010 Jul;299(1):C51-7. (PMID: 20375273)
      J Biol Chem. 1999 Nov 19;274(47):33449-54. (PMID: 10559227)
      Am J Physiol Cell Physiol. 2008 Jun;294(6):C1362-70. (PMID: 18400987)
      Gastroenterology. 2005 Aug;129(2):591-608. (PMID: 16083715)
      Neuropharmacology. 2008 Nov;55(6):1072-80. (PMID: 18687345)
      Am J Physiol Gastrointest Liver Physiol. 2007 Jan;292(1):G369-76. (PMID: 17008555)
      N Engl J Med. 2003 Jul 24;349(4):395-7. (PMID: 12878748)
      Am J Physiol Cell Physiol. 2001 Mar;280(3):C628-36. (PMID: 11171583)
      Cell. 2002 Sep 20;110(6):669-72. (PMID: 12297041)
      Am J Physiol. 1996 Sep;271(3 Pt 1):C914-22. (PMID: 8843722)
      Am J Physiol Gastrointest Liver Physiol. 2007 Mar;292(3):G779-84. (PMID: 17170025)
      Biochim Biophys Acta. 2011 Oct;1812(10):1301-13. (PMID: 20959142)
      Cell Signal. 2010 Jun;22(6):894-9. (PMID: 20060892)
      J Biol Chem. 1990 May 15;265(14):7709-12. (PMID: 2186024)
      Scand J Gastroenterol. 1997 Sep;32(9):925-32. (PMID: 9299673)
      Endocrinology. 1998 Jan;139(1):195-203. (PMID: 9421415)
      Neurogastroenterol Motil. 2009 May;21(5):534-41, e10-1. (PMID: 19222758)
      N Engl J Med. 2003 Jul 24;349(4):350-7. (PMID: 12878742)
      Gastroenterology. 2010 Jul;139(1):249-58. (PMID: 20303355)
      Gastroenterology. 2009 Dec;137(6):2074-83. (PMID: 19747920)
      Pharmacol Res. 2006 Aug;54(2):73-6. (PMID: 16750380)
      Am J Physiol Cell Physiol. 2003 Oct;285(4):C977-93. (PMID: 12788694)
      Am J Physiol Gastrointest Liver Physiol. 2010 Feb;298(2):G159-66. (PMID: 19940027)
      J Pediatr Gastroenterol Nutr. 1990 Jan;10(1):13-20. (PMID: 2324874)
      J Neurosci. 2001 Aug 15;21(16):6348-61. (PMID: 11487658)
      Annu Rev Med. 2009;60:355-66. (PMID: 19630576)
      Neurogastroenterol Motil. 2006 Jun;18(6):464-71. (PMID: 16700726)
    • Grant Information:
      R01 DK033349 United States DK NIDDK NIH HHS; P01-DK-067887 United States DK NIDDK NIH HHS; DK-71596 United States DK NIDDK NIH HHS; DK-33349 United States DK NIDDK NIH HHS; DK-74458 United States DK NIDDK NIH HHS
    • Accession Number:
      0 (Proto-Oncogene Proteins c-jun)
      0 (RNA, Messenger)
      0 (Serotonin Plasma Membrane Transport Proteins)
      62229-50-9 (Epidermal Growth Factor)
      EC 2.7.10.1 (ErbB Receptors)
    • Publication Date:
      Date Created: 20110129 Date Completed: 20110630 Latest Revision: 20211020
    • Publication Date:
      20231215
    • Accession Number:
      PMC3074988
    • Accession Number:
      10.1152/ajpgi.00563.2010
    • Accession Number:
      21273531